TRACHEAL TUBE AND AIRWAY PRODUCTS MARKET ANALYSIS

A tracheal tube is a catheter that is inserted into the trachea for the primary purpose of establishing and maintaining a patent airway and to ensure the adequate exchange of oxygen and carbon dioxide. Constant advancements made in airway products have helped clinicians reduce the risk of intubation failure and aspiration, especially in patients with traumatic injuries. This is a key aspect in the tracheal tubes and airway products market. Airway is a pathway from where air reaches to lungs. This pathway includes nose, throat, windpipe, mouth, and lungs. The airway management is a series of procedures that prevents collapsing of airway. The airway management is basically conducted in two ways through - basic and advanced techniques. Basic airway management techniques are generally non-invasive and do not require any medical devices. Advanced airway management techniques involve medical equipment and specialized training. The airway devices allow a smooth airflow during the general anesthesia and in patients who have difficulty in breathing.

Global tracheal tube and airway products market is estimated to be valued at US$ 4,140.5 million in 2022 and is expected to exhibit a CAGR of 6.6% during the forecast period (2022-2030).

Figure 1. Global Tracheal Tube and Airway Products Market Share (%), by Products Type, 2022

To learn more about this report, request sample copy

Increasing product launches of tracheal tubes and airway products by the key players is expected to drive the market growth over the forecast period.

Increasing product launches of tracheal tubes and airway products by the key players is expected to drive the market growth over the forecast period. For instance, in January 2019, Oventus Medical, a brisbane-based medical device company released a new product, O2 Vent Optima. It is used in the obstructive sleep apnea disorder. It is designed on the basis of Oventus Medical’s airway technology. It prevents collapsing of airway and unobstructed airflow from tongue, soft palate, and nose. It can be used with or without continuous positive airway pressure.

Figure 2. Global Tracheal Tube and Airway Products Market Share (%), by Region, 2022

To learn more about this report, request sample copy

Approvals of tracheal tubes and airway products by regulatory bodies are expected to accelerate the global tracheal tube and airway products market growth.

Increasing approvals of tracheal tubes and airway products by the regulatory bodies are expected to drive the global tracheal tube and airway products market growth. For instance, in October 2018, Vapotherm Inc., a medical device company received the U.S. Food & Drug Administration (FDA) approval for its respiratory assistance product, Flow Hi-VNI system. It removes heavy carbon dioxide and oxygen depleted exhaled air, and supplies with humidified oxygen-rich air through nasal cannulas.

Global Tracheal Tube and Airway Products Market – Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization had declared it a public health emergency on January 30, 2020.

COVID-19 can affect the economy in three main ways: by directly affecting production and demand of drugs, medical devices and nutritional supplements by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries, such as China, India, Saudi Arabia, U.A.E., Egypt, and others, are facing problems with regards to the transportation of drugs from one place to another.

However, the COVID-19 pandemic had a positive impact on the global tracheal tube and airway products market, owing to the increased in demand of tracheal tube and airway products during COVID-19 pandemic. For instance, in June 2022, according to the data published by the National Center for Biotechnology Information, COVID-19 pandemic has resulted in a significantly increased need for prolonged ventilation in patients with respiratory failure. Extant literature addresses indications for tracheostomy in COVID-19 patients and factors surrounding decision to proceed with tracheostomy. Special attention is required in COVID-19 positive patients with tracheostomy; due to poor pulmonary reserve and thick tenacious secretions that heightened risks to patients, but also because emergency management of tube obstruction has high aerosolization risk. Airway obstruction from mucus plugging is particularly challenging in instances of altered anatomy, as may occur with tracheocutaneous fistula with distal tracheal stenosis. Hence, demand for the tracheal tubes and airway products increased during the COVID-19 pandemic.

Global Tracheal Tube and Airway Products Market: Key Developments

In May 2022, Proxima Clinical Research, a company guiding emerging medical device and pharmaceutical companies, successfully received Safer Technologies Program (‘STeP’) Medical Device Designation, Airway Shield. Airway Shield is a mouthpiece used during endotracheal intubation (‘ET intubation’) that facilitates the insertion of an endotracheal tube and serves as a barrier during aerosol generating procedures to eliminate the spread of aerosols and droplets emitted by the patient to medical staff, thereby reducing the risk of infections and spread of viruses such as COVID-19.

Global Tracheal Tube and Airway Products Market: Restraint

The major factors that hinder growth of the global tracheal tube and airway products market include product recall by the regulatory bodies. For instance, the U.S. Food and Drug Administration initiated recall of multiple models of the Hudson RCI Sheridan and Sheridan Endotracheal Tubes of Teleflex Inc. as the tubes were getting disconnected from the circuits, on May 2019 and around 6.07 million devices were recalled.

Key Players

Major players operating in the global tracheal tube and airway products market include Teleflex Inc., Smiths Medical, Medtronic Plc., Medis Medical (UK) Ltd, VBM Medizintechnik GmbH, The Airway Company (Shikani Medical, LLC), Halyard Health, Boston Medical Products Inc., BomiMed, and Mercury Medical.